European Centre for Disease Prevention and Control. (2022) Hepatitis C - annual epidemiological report for 2020. Sweden: European Centre for Disease Prevention and Control.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Hepatitis C - annual epidemiological report for 2020.)
764kB |
External website: https://www.ecdc.europa.eu/en/publications-data/he...
- In 2020, 13 914 cases of hepatitis C were reported in 28 EU/EEA Member States. Excluding countries that only reported acute cases leaves 13 901 cases, which corresponds to a crude rate of 3.9 cases per 100 000 population.
- Of the cases reported, 6% were classified as acute, 35% as chronic, and 53% as ‘unknown’. Five percent could not be classified due to an incompatible data format.
- Hepatitis C was more commonly reported among men than women, with a male-to-female ratio of 2.2:1. The most affected age group among males was 35-44 years, and among females 25-44 years.
- Mode of transmission was reported for just 31% of cases. The most commonly reported mode was injecting drug use, which accounted for 59% of cases with complete information on transmission status.
- The interpretation of hepatitis C notification data across countries remains problematic, with ongoing differences in surveillance systems and difficulties in defining reported cases as acute or chronic. With hepatitis C, a largely asymptomatic disease until the late stages, surveillance based on notification data is challenging, with data reflecting testing practices rather than true occurrence of disease.
Item Type
Report
Publication Type
Irish-related, International, Report
Drug Type
Substances (not alcohol/tobacco), Opioid
Intervention Type
Harm reduction
Date
July 2022
Pages
8 p.
Publisher
European Centre for Disease Prevention and Control
Corporate Creators
European Centre for Disease Prevention and Control
Place of Publication
Sweden
EndNote
Subjects
G Health and disease > Disease by cause (Aetiology) > Needle (sharing / injecting)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > International
VA Geographic area > Europe > Ireland
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > International
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page